cetylpyridinium chloride anhydrous has been researched along with Bone Hypertrophy in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ereifej, L; Lewiecki, EM; Sharifi, M | 1 |
1 review(s) available for cetylpyridinium chloride anhydrous and Bone Hypertrophy
| Article | Year |
|---|---|
Sclerostin and skeletal health.
Topics: Adaptor Proteins, Signal Transducing; Animals; Antibodies, Monoclonal; Bone and Bones; Bone Density; Bone Morphogenetic Proteins; Genetic Markers; Health; Humans; Hyperostosis; Osteochondrodysplasias; Osteoporosis; Syndactyly | 2015 |